Brief: Nyxoah SA Submits Pma Supplement To FDA To Expand Genio Indication To Complete Concentric Collapse Patients
BRIEF-Nyxoah SA Submits Pma Supplement To FDA To Expand Genio Indication To Complete Concentric Collapse Patients Oct 15 (Reuters) - Nyxoah SA NYXH.BR:
NYXOAH SA: SUBMITS PMA SUPPLEMENT TO FDA TO EXPAND GENIO INDICATION TO COMPLETE CONCENTRIC COLLAPSE PATIENTS
Source text: ID:nGNX3SWRmZ
Further company coverage: NYXH.BR
((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Nyxoah SA
See all newsBelgium's Nyxoah Q3 revenue rises on US commercialization
Brief: Nyxoah SA Q3 Gross Profit EUR 5.785 Million
Brief: Nyxoah SA Submits Pma Supplement To FDA To Expand Genio Indication To Complete Concentric Collapse Patients
Brief: Nyxoah Says Co Appoints Liam Kelly As Chief Executive Officer Effective October 1
Brief: Cvrx Appoints John Landry As Chief Financial Officer